West Houston Dermatology

Welcome to WHDERM - West Houston Dermatology

BLOG

Houston Doctors on Forefront of Chronic Plaque Psoriasis Treatment

Dermatologists at Houston’s Baylor College of Medicine published an article in the January 16th issue of Archives of Dermatology called “Consensus Guidelines for the Management of Plaque Psoriasis.”  Of particular interest in this article is a table that summarizes current research and protocols for the use of eight (8) systemic psoriasis medications, including:  acitretin, cyclosporine, methotrexate, adalimumab, etanercept, infliximab, ustekinumab, and alefacep. This article is novel in its approach because its purpose is to clarify and simplify when and how to use these eight psoriasis drugs for patients who do not respond to topical treatment.  Though a review of the article and table would be of interest to psoriasis patients and their loved ones, it is not a substitute for consultation with your dermatologist who knows your medical history.  Additionally, these medications require a prescription.  Since the article is titled “Consensus guidelines” and not “unanimous or universal guidelines” the suggestions therein may not be appropriate for all patients.  Stephen Mahoney, M.D. focuses a large part of his practice on treating patients with various forms of psoriasis, including chronic plaque psoriasis.  As such he is passionate about reviewing the literature and collaborating with colleagues in improved methods of psoriasis treatment.